UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Activation of c-MET induces a stem-like phenotype in human prostate cancer

PloS one, 2011-11, Vol.6 (11), p.e26753

2011

Volltextzugriff (PDF)

Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites

The Journal of steroid biochemistry and molecular biology, 2024-02, Vol.236, p.106446-106446, Article 106446

2024

Volltextzugriff (PDF)

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling

The Prostate, 2022-04, Vol.82 (5), p.505-516

2022

Volltextzugriff (PDF)

Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition

Molecular cancer therapeutics, 2024-05, Vol.23 (5), p.711

2024

Volltextzugriff (PDF)

Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer

Frontiers in oncology, 2022-06, Vol.12, p.877613-877613

2022

Volltextzugriff (PDF)

A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling

The Prostate, 2019-06, Vol.79 (9), p.937-948

2019

Volltextzugriff (PDF)

Abstract B21: Establishment of a novel spontaneous prostate cancer liver metastasis model

Clinical cancer research, 2016-08, Vol.22 (16_Supplement), p.B21-B21

2016

Volltextzugriff (PDF)

Abstract C97: Beyond intratumoural steroidogenesis: abiraterone resistance mediated by AR variants and glucocorticoid receptor signalling

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.C97-C97

2015

Volltextzugriff (PDF)

Abstract C133: Adrenal stimulation of CRPC growth in an in vitro co-culture model

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C133-C133

2013

Volltextzugriff (PDF)

Zebrabow as in vivo model system to monitor vesicles mediated transfer in cancer

Journal of extracellular vesicles, 2018-01, Vol.7, p.94-94

2018

Volltextzugriff (PDF)

Profiling of Antibody Production against Xenograft-released Proteins by Protein Microarrays Discovers Prostate Cancer Markers

Journal of proteome research, 2012-02, Vol.11 (2), p.728-735

2012

Volltextzugriff (PDF)

Characterization of the human spr2 promoter : induction after UV irradiation or TPA treatment and regulation during differentiation of cultured primary keratinocytes

Nucleic acids research, 1990-08, Vol.18 (15), p.4401-4407

1990

Volltextzugriff (PDF)

Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers

Human pathology, 1996-07, Vol.27 (7), p.720-727

1996

Volltextzugriff (PDF)

Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells

Gene, 1989-12, Vol.84 (2), p.407-417

1989

Volltextzugriff (PDF)

Loss and gain of chromosomes 1, 18, and Y in prostate cancer

The Prostate, 1994-12, Vol.25 (6), p.281-291

1994

Volltextzugriff (PDF)

Tissue culture loss of aneuploid cells from carcinomas of the prostate

Genes chromosomes & cancer, 1993-09, Vol.8 (1), p.22-27

1993

Volltextzugriff (PDF)

Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines

Urolithiasis, 1999-02, Vol.27 (1), p.3-8

1999

Volltextzugriff (PDF)

Specific Cytogenetic Aberrations in Two Novel Human Prostatic Cell Lines Immortalized by Human Papillomavirus Type 18 DNA

Cancer genetics and cytogenetics, 1997-12, Vol.99 (2), p.108-115

1997

Volltextzugriff (PDF)

Interphase cytogenetics of prostate carcinoma

Cancer genetics and cytogenetics, 1992-10, Vol.63 (2), p.151-151

1992

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of c-MET induces a stem-like phenotype in human prostate cancer

Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling

Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition

Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer

A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling

Abstract B21: Establishment of a novel spontaneous prostate cancer liver metastasis model

Abstract C97: Beyond intratumoural steroidogenesis: abiraterone resistance mediated by AR variants and glucocorticoid receptor signalling

Abstract C133: Adrenal stimulation of CRPC growth in an in vitro co-culture model

Zebrabow as in vivo model system to monitor vesicles mediated transfer in cancer

Profiling of Antibody Production against Xenograft-released Proteins by Protein Microarrays Discovers Prostate Cancer Markers

Characterization of the human spr2 promoter : induction after UV irradiation or TPA treatment and regulation during differentiation of cultured primary keratinocytes

Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers

Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells

Loss and gain of chromosomes 1, 18, and Y in prostate cancer

Tissue culture loss of aneuploid cells from carcinomas of the prostate

Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines

Specific Cytogenetic Aberrations in Two Novel Human Prostatic Cell Lines Immortalized by Human Papillomavirus Type 18 DNA

Interphase cytogenetics of prostate carcinoma

Suchergebnisse filtern